Aequus Pharmaceuticals Inc. and Advanced Ophthalmic Innovations announced the signing of an exclusive distribution agreement for the PAUL® glaucoma drainage device in Canada. Under the terms of the agreement, AOI will supply the PAUL®? device and gain market authorization, and Aequus will be responsible for the marketing, distribution, sales, and supporting ongoing regulatory and market access activities.